ECJ Judgment Fails to Clarify Rules on Information and Advertising
This article was originally published in SRA
Executive Summary
The judgment by the European Court of Justice in the Damgaard case provides little operational guidance on how to differentiate unlawful advertising for medicinal products from nonpromotional information disseminated by independent journalists, scientists and more generally any third party1.